Sanjay S. Subramanian
2023
In 2023, Sanjay S. Subramanian earned a total compensation of $1M as Senior Vice President and Chief Financial Officer at Inozyme Pharma, a 17% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $172,000 |
|---|---|
| Option Awards | $406,704 |
| Salary | $444,333 |
| Other | $9,900 |
| Total | $1,032,937 |
Subramanian received $444.3K in salary, accounting for 43% of the total pay in 2023.
Subramanian also received $172K in non-equity incentive plan, $406.7K in option awards and $9.9K in other compensation.
Rankings
In 2023, Sanjay S. Subramanian's compensation ranked 1,138th out of 2,821 executives tracked by ExecPay. In other words, Subramanian earned more than 59.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,138 out of 2,821 | 60th |
Division Manufacturing | 686 out of 1,551 | 56th |
Major group Chemicals And Allied Products | 459 out of 877 | 48th |
Industry group Drugs | 448 out of 840 | 47th |
Industry Pharmaceutical Preparations | 306 out of 605 | 49th |
Source: SEC filing on April 26, 2024.
Subramanian's colleagues
We found three more compensation records of executives who worked with Sanjay S. Subramanian at Inozyme Pharma in 2023.